Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Samil Pharmaceutical Co. Ltd. (000520)
Market Closed
15 Jun, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
7,520.
00
+260
+3.5813%
₩
151.79B
Market Cap
-
P/E Ratio
290.91%
Div Yield
89,324
Volume
0
Eps
₩
7,260
Previous Close
Watching
Watch
Add Transaction
Day Range
7,300
7,520
Year Range
6,620
12,860
Want to track
000520
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Samil Pharmaceutical Co. Ltd. (000520) Statistics
Valuation metrics
Market Cap
151.79B
Enterprise value
318.97B
Trailing P/E (ttm)
-4.25
Forward P/E
83.15
PEG ratio
0.05
Price/Sales (ttm)
0.73
Price/Book (mrq)
1.2
Enterprise Value/Revenue
1.51
Enterprise Value/EBITDA
-24.99
Overview
Shares outstanding
21.23M
Float
16M
Shares short
-
% Held by insiders
0.26%
% Held by institutions
0.01%
Average volume (10 days)
83.03K
Average volume (90 days)
228.12K
Price summary
52-Week low
6,620
52-Week high
12,860
Beta
0.43
50-Day moving average
8,097.5
200-Day moving average
9,638.57
Dividends and splits
Forward annual dividend rate
290.91
Forward annual dividend yield
0.0393%
Trailing annual dividend rate
72.73
Trailing annual dividend yield
0.0098%
5-Year annual dividend yield
0.73%
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:1
Last split Date
24 Mar 2023
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
-0.17%
Operating margin
-0.13%
Operational effectiveness
Return on assets
-0.1%
Return on equity
-0.26%
Income Statement
Revenue (ttm)
210.25B
Revenue per share (ttm)
9,897.47
Quarterly revenue growth (yoy)
-0.08%
Gross profit (ttm)
77.12B
EBITDA
-14.74B
Net income to common (ttm)
-34.66B
Diluted EPS (ttm)
-1,707.72
Quarterly earnings growth (yoy)
0%
Balance Sheet
Total cash (mrq)
6.41B
Total cash per share (mrq)
55.82
Total debt (mrq)
164.02B
Total Debt/Equity (mrq)
1.29
Current ratio (mrq)
0.46%
Book value per share (mrq)
6,040.88
Cash Flow
Cash flow statement
568.16M
Levered free cash flow (LFCF)
-6.76B